Covid-19: Study Confirms Benefits of High-Titer Plasma Early in Disease Course
Jan 15, 2021 Death benefit not seen in patients on mechanical ventilation Among patients hospitalized with Covid-19 not receiving mechanical ventilation, treatment with high-titer convalescent plasma was associated with a lower risk for death than those receiving plasma with low antibody, according to peer-reviewed findings from a retrospective analysis of more than 3,000 patients. In addition, patients who received convalescent plasma very early – within 3 days of receiving a diagnosis of Covid-19 – had a lower risk of death than those who received the treatment later in the disease cour...
Source: physiciansweekly.com